Aleks Radovic-Moreno, PhD
Aleks Radovic-Moreno, PhD, is a Partner at Longwood Fund, where he is involved in building and supporting portfolio companies including serving as founding CEO of Longwood-founded Weaver Bio and Be Bio, where he was Co-Founder and President. Aleks was previously Senior Vice President at PureTech Health, where he was a co-founder and member of the […]
Christoph Westphal, MD PhD
Dr. Westphal was the founder, CEO, and lead investor of Alnylam, and 6 additional biotechs that completed IPOs. He is the co-founder and General Partner of Longwood Fund and has spent over 20 years as a biotech CEO, entrepreneur, and investor. Dr. Westphal has been the co-founder, CEO, and lead investor of seven biotechnology companies […]
Kevin Lewis
Kevin Lewis is Longwood Fund’s Controller. Kevin has significant experience in private equity financial operations at firms including Leerink Partners, Bain & Company, Ernst & Young, and most recently at Audax Group. He works on Longwood’s financial operations and supports the financial aspects of Longwood-founded companies.
Arielle Jackson, BBA
Arielle Jackson is the Head of Corporate Communications and Industry Engagement for Longwood Fund. She joined Longwood Fund in 2017 to spearhead Longwood’s investor relations efforts and currently leads Longwood Fund’s corporate communications efforts with a focus on building meaningful relationships with investors, partners, and stakeholders in the biopharma industry. Arielle also co-founded and runs […]
Lea Hachigian, PhD
Dr. Lea Hachigian is Senior Vice President of Corporate Strategy and Operations at Newleos Therapeutics and a Venture Partner at Longwood Fund. She has a track record of building and scaling biotechnology companies from inception through clinical development. Dr. Hachigian has co-founded multiple biotechnology companies, including Be Biopharma, Immunitas Therapeutics (President and Board Director), TScan […]
Rich Aldrich, MBA
Rich Aldrich is a Co-Founder and Partner of Longwood Fund. He has co-founded and helped to build several successful biotech companies including Sirtris Pharmaceuticals (NASDAQ: SIRT acquired by GlaxoSmithKline); Concert Pharmaceuticals (acquired by Sun Pharmaceuticals) where he served as Chair of the Board; and Longwood portfolio companies Alnara Pharmaceuticals (acquired by Eli Lilly), Verastem (NASDAQ: […]